Audio
Archive
2013
January
February
March
April
May
2012
January
February
March
April
May
June
July
August
September
October
November
December
2011
January
February
March
April
May
June
July
August
September
October
November
December
2010
January
February
March
April
May
June
July
August
September
October
November
December
2009
January
February
March
April
May
June
July
August
September
October
November
December
2008
January
February
March
April
May
June
July
August
September
October
November
December
2007
June
July
August
September
October
November
December
Subscribe
Oct. 17, 2008
A New Approach for Antibiotics
|
|
|
Tweet |
| Antibiotic resistance is one of the biggest threats in medicine today. In this segment, Ira and guests talk about new approaches to developing antibiotics that could lead to new methods for treating drug-resistant tuberculosis and other diseases. The work, published this week in the journal Cell, involves blocking the action of RNA polymerase in bacteria. RNA polymerase is needed to transcribe the genetic instructions in DNA into RNA -- with out it, a cell can't manufacture the proteins it needs to function. The researchers are studying how three compounds, myxopyronin, corallopyronin, and ripostatin, block the action of RNA polymerase and achieve antibiotic properties. The concepts could lead to a new class of braod-spectrum antibiotics, they say. We'll find out more. |
Produced by Christopher Intagliata, Associate Senior Producer
Guests
-
Richard H. Ebright
Investigator for the Howard Hughes Medical Institute
Professor, Department of Chemistry and Chemical Biology
Laboratory director at the Waksman Institute of Microbiology
Rutgers University
Piscataway, New Jersey


Discussion